合生元益生菌治疗自发性高血压相关机制的代谢组学研究

张莉敏; 陈宇峰; 战莹; 武晓丹; 周玉虹

doi:10.3969/j.issn.1006-0111.2019.02.008

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

《药学实践与服务》杂志目前不收取审稿费、版面费、加急费等费用，如收到邮件声称是编辑部X编辑，要求加作者微信的，请谨防财产损失！编辑部用于作者校对时绑定微信的邮件通过[email protected]发送，标题是《药学实践与服务》XML数字出版服务微信绑定，请区分开。

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹

文章导航 > 药学实践与服务 > 2019 > 37(2): 141-145

张莉敏, 陈宇峰, 战莹, 武晓丹, 周玉虹. 合生元益生菌治疗自发性高血压相关机制的代谢组学研究[J]. 药学实践与服务, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008

引用本文:

ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008

Citation:

ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1.
复旦大学附属华东医院, 上海 200050
2.
原沈阳军区总医院, 辽宁沈阳 110016
3.
沈阳药科大学药学院, 辽宁沈阳 110016

基金项目: 辽宁省自然科学基金（20170540954）

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1.
Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China
2.
General Hospital of Shenyang Military Area Command, Shenyang 110016, China
3.
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

摘要: 目的应用代谢组学相关技术，从表观水平探索合生元制剂通过调节肠道菌群达到降压效应的可能作用机制。方法将14只自发性高血压大鼠随机分为2组，模型组和治疗组各7只，另取7只Wistar Kyoto大鼠作为对照组，采用超高效液相色谱-四级杆飞行时间串联质谱（UHPLC-Q-TOF/MS）技术对对照组、原发性高血压模型组和合生元制剂治疗组的大鼠模型回肠段进行代谢组学分析，筛选合生元制剂治疗自发性高血压的潜在生物学标志物。结果通过对代谢组学的分析，确定了对照组与模型组之间具有显著差异的27种代谢物。在这些代谢物中，与模型组相比，治疗组中溶血磷脂酰乙醇胺（LysoPE）和磷脂酰胆碱（PC）可以显著被重新调节。结论合生元制剂可以通过改变肠道微生物群的结构，调节LysoPE和PC相关信号通路，进而改善自发性高血压状态；代谢组学有助于从分子水平理解自发性高血压发病机制及合生元制剂的降压机制。
- 自发性高血压大鼠 /
- 代谢组 /
- 合生元 /
- 超高效液相色谱
Abstract: Objective To explore the possible mechanism of synergistic effect of synbiotic preparations by regulating intestinal flora to achieve antihypertensive effect by the metabolomics-related techniques. Methods Fourteen spontaneously hypertensive rats were randomly divided into two groups,7 rats in each of the model group and the treatment group,and another 7 Wistar Kyoto rats were used as the control group.Ileum metabolic profiling among the control group,Spontaneous hypertension model group and symbiotic treatment group were analyzed by ultra-high performance liquid chromatography coupled with tandem quadrupole time of flight mass spectrometry (UHPLC-Q-TOF MS).The potential biomarkers for the treatment of spontaneous hypertension were selected. Results In additional,27 metabolites with significant differences between the control and model group were identified by analysis of metabonomics.Among these metabolites,LysoPE and PC could be significantly re-regulated in the treatment group,compared with the model group. Conclusion Synbiotics could improve the status of spontaneous hypertension by changing the structure of the intestinal microbiota,regulating LysoPE and PC-related signaling pathways.Metabolomics could help to understand the pathogenesis of essential hypertension and the hypotensive mechanism of synbiotics at the molecular level.
- spontaneously hypertensive rats /
- metabolomics /
- synbiotics /
- UHPLC

[1]	中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
[2]	ZHENG Y,YU Alexander D,et al. Metabolomics and incident hypertension among blacks:the atherosclerosis risk in communities study[J]. Hypertension,2013,62(2):398-403.
[3]	YANG T,SANTISTEBAN M M,RODRIGUEZ V,et al. Gut dysbiosis is linked to hypertension[J].Hypertension,2015,65(6):1331-1340.
[4]	NICHOLSON J K,LINDON J C,HOLMES E.Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]. Xenobiotica,1999,29(11):1181-1189.
[5]	SCHNACKENBERG L K B R. Monitoringthe health to disease continuumwith global metabolicprofilingandsystemsbiology[J]. Pharmacogenomics,2006,7(7):1077-1086.
[6]	AUSTDAL M,TANGERAS L H,SKRASTAD R B,et al. First trimester urine and serum metabolomics for prediction of preeclampsia and festational hypertension:a prospective screening study[J].Int J Mol Sci,2015,16(9):21520-21538.
[7]	RYU S B.Phospholipid-derived signaling mediated by phospholipase A in plants[J]. Trends Plant Sci,2004,9(5):229-235.
[8]	ROCK C O,JACKOWSKI S,CRONAN J E,et al.Lipid metabolism in prokaryotes[J]. Biochem Lip Lipoprot Membr, 1996:35-74.
[9]	ZHAO Q,LI X M,LIU H N,et al. Metabolic map of osthole and its effect on lipids[J]. Xenobiotica. 2018,48(3):285-299.

[1]	张俊丽, 李媛媛, 尹静, 杨鸿源, 白耀武. 咪达唑仑调节PINK1/PARKIN信号通路对缺血性脑卒中大鼠神经元损伤的影响 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202405024
[2]	冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽. 菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202407038
[3]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2025, 43(3): 143-150. doi: 10.12206/j.issn.2097-2024.202312027
[4]	舒飞, 孙蕊, 宋凯, 张元林, 闫家铭, 舒丽芯. 粉-液双室袋产品的综合评价 . 药学实践与服务, 2025, 43(2): 92-96. doi: 10.12206/j.issn.2097-2024.202312009
[5]	徐尧, 马春辉, 李志勇. 高血压对心血管纤维化及sFRP2表达的影响 . 药学实践与服务, 2025, 43(4): 1-5. doi: 10.12206/j.issn.2097-2024.202409055
[6]	吴海韵, 杨甜, 张弛, 梁文仪, 苏娟. 气相色谱-离子迁移谱技术在中药研究中的应用进展 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202409007
[7]	晁亮, 王辉, 沈淑琦, 游飘雪, 冀凯宏, 洪战英. 基于UHPLC-Q/TOF-MS代谢组学策略的葛根-知母药对防治阿尔茨海默病的药效与作用机制研究 . 药学实践与服务, 2025, 43(1): 30-40. doi: 10.12206/j.issn.2097-2024.202409035
[8]	魏雨辰, 田家盛, 王道鑫, 凌期盛, 王治, 缪朝玉. 烟酰胺单核苷酸口服给药对高血压大鼠的影响 . 药学实践与服务, 2025, 43(5): 1-9. doi: 10.12206/j.issn.2097-2024.202412006
[9]	毛智毅, 王筱燕, 陈晓颖, 汤逸斐. 度拉糖肽联合二甲双胍对肥胖型2型糖尿病患者机体代谢、体脂成分及血清脂肪因子的影响 . 药学实践与服务, 2024, 42(7): 305-309. doi: 10.12206/j.issn.2097-2024.202305032
[10]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049

点击查看大图

计量

文章访问数: 4063
HTML全文浏览量: 532
PDF下载量: 335
被引次数: 0

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1. 复旦大学附属华东医院, 上海 200050

2. 原沈阳军区总医院, 辽宁沈阳 110016

3. 沈阳药科大学药学院, 辽宁沈阳 110016

基金项目: 辽宁省自然科学基金（20170540954）

收稿日期: 2018-08-03
修回日期: 2018-11-30

关键词:

自发性高血压大鼠 /

代谢组 /

合生元 /

超高效液相色谱

摘要: 目的应用代谢组学相关技术，从表观水平探索合生元制剂通过调节肠道菌群达到降压效应的可能作用机制。方法将14只自发性高血压大鼠随机分为2组，模型组和治疗组各7只，另取7只Wistar Kyoto大鼠作为对照组，采用超高效液相色谱-四级杆飞行时间串联质谱（UHPLC-Q-TOF/MS）技术对对照组、原发性高血压模型组和合生元制剂治疗组的大鼠模型回肠段进行代谢组学分析，筛选合生元制剂治疗自发性高血压的潜在生物学标志物。结果通过对代谢组学的分析，确定了对照组与模型组之间具有显著差异的27种代谢物。在这些代谢物中，与模型组相比，治疗组中溶血磷脂酰乙醇胺（LysoPE）和磷脂酰胆碱（PC）可以显著被重新调节。结论合生元制剂可以通过改变肠道微生物群的结构，调节LysoPE和PC相关信号通路，进而改善自发性高血压状态；代谢组学有助于从分子水平理解自发性高血压发病机制及合生元制剂的降压机制。

English Abstract

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China

2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China

3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

Received Date: 2018-08-03
Rev Recd Date: 2018-11-30

Keywords:

Abstract: Objective To explore the possible mechanism of synergistic effect of synbiotic preparations by regulating intestinal flora to achieve antihypertensive effect by the metabolomics-related techniques. Methods Fourteen spontaneously hypertensive rats were randomly divided into two groups,7 rats in each of the model group and the treatment group,and another 7 Wistar Kyoto rats were used as the control group.Ileum metabolic profiling among the control group,Spontaneous hypertension model group and symbiotic treatment group were analyzed by ultra-high performance liquid chromatography coupled with tandem quadrupole time of flight mass spectrometry (UHPLC-Q-TOF MS).The potential biomarkers for the treatment of spontaneous hypertension were selected. Results In additional,27 metabolites with significant differences between the control and model group were identified by analysis of metabonomics.Among these metabolites,LysoPE and PC could be significantly re-regulated in the treatment group,compared with the model group. Conclusion Synbiotics could improve the status of spontaneous hypertension by changing the structure of the intestinal microbiota,regulating LysoPE and PC-related signaling pathways.Metabolomics could help to understand the pathogenesis of essential hypertension and the hypotensive mechanism of synbiotics at the molecular level.

引用本文:

Citation:

ZHANG Limin, CHEN Yufeng, ZHAN Ying, WU Xiaodan, ZHOU Yuhong. Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(2): 141-145. doi: 10.3969/j.issn.1006-0111.2019.02.008

全文HTML

参考文献 (9)

下载: 全尺寸图片幻灯片

返回文章

用微信扫码二维码

分享至好友和朋友圈

主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

电话: （021）81871324,81871397 E-mail: [email protected]

网站备案号沪ICP备05003363号-1

本系统由北京仁和汇智信息技术有限公司开发

留言板

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

计量

出版历程

合生元益生菌治疗自发性高血压相关机制的代谢组学研究

doi: 10.3969/j.issn.1006-0111.2019.02.008

1. 复旦大学附属华东医院, 上海 200050 2. 原沈阳军区总医院, 辽宁 沈阳 110016 3. 沈阳药科大学药学院, 辽宁 沈阳 110016

English Abstract

Metabonomics study on the antihypertensive mechanism of lactobacillus and bifidobacterium in the spontaneous hypertensive rats

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China 2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China 3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

全文HTML

目录

1. 复旦大学附属华东医院, 上海 200050

2. 原沈阳军区总医院, 辽宁沈阳 110016

3. 沈阳药科大学药学院, 辽宁沈阳 110016

1. Huadong Hospital Affiliated to Fudan University, Shanghai 200050, China

2. General Hospital of Shenyang Military Area Command, Shenyang 110016, China

3. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China